How would you approach treatment selection for an elderly woman with de novo metastatic HER2+ breast cancer with lung and brain mets?

1 Answers

Mednet Member

Medical Oncology · University of Pittsburgh School of Medicine

This depends on performance status. For good PS, T-DXd. For poorer PS, T-DM1. I would consider SRS if needed for the brain mets.